Widaplik NDC 24338-001

NDC codes

FDA NDC Directory

Product NDC (as listed)24338-001Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24338-0001Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
24338-001-30	24338000130	30 TABLET in 1 BOTTLE (24338-001-30)Marketed from Oct 20, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Widaplik
Generic name (nonproprietary): telmisartan, amlodipine and indapamide
Active ingredients: Telmisartan — 10 mg/1Amlodipine besylate — 1.25 mg/1Indapamide — .625 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Azurity Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 219423
Marketing start: Oct 20, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)Calcium Channel Antagonists (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)Dihydropyridines (Chemical structure)Increased Diuresis (Physiologic effect)
Identifiers: Product ID 24338-001_e0af7498-0dc6-4a30-a103-e30ae36c794eSPL ID e0af7498-0dc6-4a30-a103-e30ae36c794eSPL set ID a30ff81d-420b-40ea-83d8-670260a93fffRxCUI 2727452, 2727458, 2727460, 2727462, 2727463, 2727465UNII 864V2Q084H, F089I0511L, U5SYW473RQUPC 0324338001301, 0324338002308, 0324338003305
Pharmacologic class: Angiotensin 2 Receptor Blocker; Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker; Thiazide-like Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424338000130 followed by a unit qualifier and the quantity

Package 24338-0001-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 3, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Widaplik (telmisartan/amlodipine/indapamide) is indicated for the treatment of hypertension in adult patients, to lower blood pressure. Widaplik may be used as initial therapy in patients likely to need multiple drugs to achieve blood pressure goals. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including angiotensin II receptor blockers, dihydropyridine calcium channel blockers and thiazide-like diuretics. There are no controlled trials demonstrating risk reduction with Widaplik. Contro…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 219423

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 219423
Product	Strength	Form · route	Labeler	Product NDC
Widapliktelmisartan, amlodipine and indapamide	Telmisartan 40 mg/1 + 2 more ingredients	TabletOral	Azurity Pharmaceuticals, Inc.	24338-003
Widapliktelmisartan, amlodipine and indapamide	Telmisartan 20 mg/1 + 2 more ingredients	TabletOral	Azurity Pharmaceuticals, Inc.	24338-002